Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/21634Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | McLachlan, Gina | - |
| dc.contributor.author | Keith, Claire | - |
| dc.contributor.author | Frauman, Albert G | - |
| dc.date | 2019-08-16 | - |
| dc.date.accessioned | 2019-08-26T06:32:29Z | - |
| dc.date.available | 2019-08-26T06:32:29Z | - |
| dc.date.issued | 2019-09 | - |
| dc.identifier.citation | Medical Journal of Australia 2019; 211(5): 237-337.e1 | - |
| dc.identifier.uri | https://ahro.austin.org.au/austinjspui/handle/1/21634 | - |
| dc.language.iso | eng | - |
| dc.subject | Adverse drug reactions | - |
| dc.subject | Diabetes mellitus, type 2 | - |
| dc.subject | Drug-related side effects and adverse reactions | - |
| dc.title | Diabetic ketoacidosis with sodium-glucose cotransporter type 2 inhibitors: a case series. | - |
| dc.type | Journal Article | - |
| dc.identifier.journaltitle | Medical Journal of Australia | - |
| dc.identifier.affiliation | Austin Health, Heidelberg, Victoria, Australia | - |
| dc.identifier.affiliation | University of Melbourne, Melbourne, VIC | en |
| dc.identifier.doi | 10.5694/mja2.50302 | - |
| dc.identifier.orcid | 0000-0002-7122-164X | - |
| dc.identifier.pubmedid | 31420875 | - |
| dc.type.austin | Letter | - |
| local.name.researcher | Frauman, Albert G | |
| item.fulltext | No Fulltext | - |
| item.grantfulltext | none | - |
| item.cerifentitytype | Publications | - |
| item.openairetype | Journal Article | - |
| item.languageiso639-1 | en | - |
| item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
| crisitem.author.dept | Pharmacy | - |
| crisitem.author.dept | Pharmacy | - |
| crisitem.author.dept | Clinical Pharmacology and Therapeutics | - |
| Appears in Collections: | Journal articles | |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.